Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
ProMIS Neurosciences, Inc. discovers and develops antibody therapies and therapeutic vaccines neurodegenerative diseases and other misfolded protein diseases in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins. Its lead product candidates comprise of PMN310, a monoclonal antibody (mAb) for toxic oligomers in AD; PMN267, a TDP-43; and PMN442, a mAb targeting toxic a-syn oligomers and seeding fibrils. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences, Inc. in July 2015. ProMIS Neurosciences, Inc. was incorporated in 2004 and is headquartered in Toronto, Canada. more
Time Frame | PMN | Sector | S&P500 |
---|---|---|---|
1-Week Return | -10.31% | 1.76% | -2.5% |
1-Month Return | 7.53% | 0.33% | -3.91% |
3-Month Return | - | -8.58% | -0.59% |
6-Month Return | -54.53% | -4.26% | 3.45% |
1-Year Return | -64.41% | 1.27% | 22.31% |
3-Year Return | -86.11% | 5.33% | 25% |
5-Year Return | -89.58% | 38.09% | 77.23% |
10-Year Return | -83.33% | 102.29% | 188.04% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 920.18 | 1.40K | 8.14K | 8.14K | - | [{"date":"2019-12-31","value":11.31,"profit":true},{"date":"2020-12-31","value":17.22,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Cost of Revenue | - | 3.18M | 5.85M | 21.78M | 10.44M | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":14.61,"profit":true},{"date":"2021-12-31","value":26.86,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":47.95,"profit":true}] |
Gross Profit | 920.18 | (3.18M) | (5.84M) | (21.78M) | (10.44M) | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-345774.48,"profit":false},{"date":"2021-12-31","value":-635020.25,"profit":false},{"date":"2022-12-31","value":-2367060.9,"profit":false},{"date":"2023-12-31","value":-1135099.33,"profit":false}] |
Gross Margin | 100.00% | (227042.27%) | (71796.84%) | (267625.31%) | (Infinity%) | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-227042.27,"profit":false},{"date":"2021-12-31","value":-71796.84,"profit":false},{"date":"2022-12-31","value":-267625.31,"profit":false},{"date":"2023-12-31","value":null,"profit":false}] |
Operating Expenses | 5.66M | 4.44M | 8.26M | 23.38M | 8.45M | [{"date":"2019-12-31","value":24.22,"profit":true},{"date":"2020-12-31","value":19,"profit":true},{"date":"2021-12-31","value":35.34,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":36.15,"profit":true}] |
Operating Income | (5.66M) | (4.44M) | (8.25M) | (23.38M) | (18.90M) | [{"date":"2019-12-31","value":-566212115,"profit":false},{"date":"2020-12-31","value":-444053452,"profit":false},{"date":"2021-12-31","value":-824967295,"profit":false},{"date":"2022-12-31","value":-2337991200,"profit":false},{"date":"2023-12-31","value":-1889769300,"profit":false}] |
Total Non-Operating Income/Expense | - | 1.22M | (1.91M) | 6.92M | 1.27M | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":17.67,"profit":true},{"date":"2021-12-31","value":-27.6,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":18.31,"profit":true}] |
Pre-Tax Income | (5.66M) | (4.44M) | (9.24M) | (18.06M) | (17.51M) | [{"date":"2019-12-31","value":-566212115,"profit":false},{"date":"2020-12-31","value":-444053452,"profit":false},{"date":"2021-12-31","value":-924253345,"profit":false},{"date":"2022-12-31","value":-1806226300,"profit":false},{"date":"2023-12-31","value":-1750614200,"profit":false}] |
Income Taxes | - | 0.14 | 415.02K | (5.32M) | (167.90K) | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-1281.28,"profit":false},{"date":"2023-12-31","value":-40.45,"profit":false}] |
Income After Taxes | - | (4.44M) | (9.66M) | (12.74M) | (17.34M) | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-444053466,"profit":false},{"date":"2021-12-31","value":-965755845,"profit":false},{"date":"2022-12-31","value":-1274461400,"profit":false},{"date":"2023-12-31","value":-1733824700,"profit":false}] |
Income From Continuous Operations | (5.66M) | (4.44M) | (9.24M) | (18.06M) | (16.90M) | [{"date":"2019-12-31","value":-566212115,"profit":false},{"date":"2020-12-31","value":-444053452,"profit":false},{"date":"2021-12-31","value":-924253345,"profit":false},{"date":"2022-12-31","value":-1806226300,"profit":false},{"date":"2023-12-31","value":-1689755800,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (5.66M) | (4.44M) | (9.66M) | (12.74M) | (17.51M) | [{"date":"2019-12-31","value":-566212115,"profit":false},{"date":"2020-12-31","value":-444053452,"profit":false},{"date":"2021-12-31","value":-965755910,"profit":false},{"date":"2022-12-31","value":-1274461400,"profit":false},{"date":"2023-12-31","value":-1750614200,"profit":false}] |
EPS (Diluted) | (0.04) | (1.32) | (1.72) | (3.36) | (1.33) | [{"date":"2019-12-31","value":-4,"profit":false},{"date":"2020-12-31","value":-131.91,"profit":false},{"date":"2021-12-31","value":-172.34,"profit":false},{"date":"2022-12-31","value":-336,"profit":false},{"date":"2023-12-31","value":-132.81,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
PMN | |
---|---|
Cash Ratio | 8.19 |
Current Ratio | 9.30 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
PMN | |
---|---|
ROA (LTM) | -480.73% |
ROE (LTM) | -1098.51% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
PMN | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.70 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.30 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
PMN | |
---|---|
Trailing PE | 25.75 |
Forward PE | NM |
P/S (TTM) | 5168.19 |
P/B | 4.63 |
Price/FCF | NM |
EV/R | 3868.08 |
EV/Ebitda | NM |
ProMIS Neurosciences Inc. (PMN) share price today is $1
Yes, Indians can buy shares of ProMIS Neurosciences Inc. (PMN) on Vested. To buy ProMIS Neurosciences Inc. from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in PMN stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of ProMIS Neurosciences Inc. (PMN) via the Vested app. You can start investing in ProMIS Neurosciences Inc. (PMN) with a minimum investment of $1.
You can invest in shares of ProMIS Neurosciences Inc. (PMN) via Vested in three simple steps:
The 52-week high price of ProMIS Neurosciences Inc. (PMN) is $3.1. The 52-week low price of ProMIS Neurosciences Inc. (PMN) is $0.87.
The price-to-earnings (P/E) ratio of ProMIS Neurosciences Inc. (PMN) is 25.75
The price-to-book (P/B) ratio of ProMIS Neurosciences Inc. (PMN) is 4.63
The dividend yield of ProMIS Neurosciences Inc. (PMN) is 0.00%
The market capitalization of ProMIS Neurosciences Inc. (PMN) is $33.18M
The stock symbol (or ticker) of ProMIS Neurosciences Inc. is PMN